# Jin He

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jin-he-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,454 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 68 |
| i10-index | 255 |
| OpenAlex ID | https://openalex.org/A5078198832 |
| ORCID iD | https://orcid.org/0000-0001-9149-2247 |
| Works | 638 |

## Researcher papers

- [Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma](https://scholariq.org/papers/patterns-timing-and-predictors-of-recurrence-following-pancreatectomy-for/)
- [Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/neuroendocrine-and-adrenal-tumors-version-2-2021-nccn-clinical-practice/)
- [Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers](https://scholariq.org/papers/combined-circulating-tumor-dna-and-protein-biomarker-based-liquid-biopsy-for-the/)
- [Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma](https://scholariq.org/papers/multi-institutional-validation-study-of-the-american-joint-commission-on-cancer/)
- [Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma](https://scholariq.org/papers/deleterious-germline-mutations-in-patients-with-apparently-sporadic-pancreatic/)
- [Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection](https://scholariq.org/papers/survival-in-locally-advanced-pancreatic-cancer-after-neoadjuvant-therapy-and/)
- [NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018](https://scholariq.org/papers/nccn-guidelines-insights-neuroendocrine-and-adrenal-tumors-version-2-2018/)
- [Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma](https://scholariq.org/papers/defining-and-predicting-early-recurrence-in-957-patients-with-resected/)
- [Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity](https://scholariq.org/papers/neoadjuvant-cabozantinib-and-nivolumab-convert-locally-advanced-hepatocellular/)
- [The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival](https://scholariq.org/papers/the-multicenter-cancer-of-pancreas-screening-study-impact-on-stage-and-survival/)
- [Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood](https://scholariq.org/papers/promoter-methylation-of-adamts1-and-bnc1-as-potential-biomarkers-for-early/)
- [Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts](https://scholariq.org/papers/prospective-multi-institutional-real-time-next-generation-sequencing-of/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.